Barriers to integrating gene profiling for stage II colon cancer
Publication
, Journal Article
Kopetz, S; Abbruzzese, JL
Published in: Clinical Cancer Research
December 15, 2009
The identification of high-risk subsets of colon cancers has undergone extensive study over the years, and multidimensional gene signatures have shown promise for colon cancer. However, several hurdles need to be overcome in order to show the benefit of this approach and successfully apply them to the clinic. © 2009 American Association for Cancer Research.
Duke Scholars
Published In
Clinical Cancer Research
DOI
ISSN
1078-0432
Publication Date
December 15, 2009
Volume
15
Issue
24
Start / End Page
7451 / 7452
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kopetz, S., & Abbruzzese, J. L. (2009). Barriers to integrating gene profiling for stage II colon cancer. Clinical Cancer Research, 15(24), 7451–7452. https://doi.org/10.1158/1078-0432.CCR-09-2523
Kopetz, S., and J. L. Abbruzzese. “Barriers to integrating gene profiling for stage II colon cancer.” Clinical Cancer Research 15, no. 24 (December 15, 2009): 7451–52. https://doi.org/10.1158/1078-0432.CCR-09-2523.
Kopetz S, Abbruzzese JL. Barriers to integrating gene profiling for stage II colon cancer. Clinical Cancer Research. 2009 Dec 15;15(24):7451–2.
Kopetz, S., and J. L. Abbruzzese. “Barriers to integrating gene profiling for stage II colon cancer.” Clinical Cancer Research, vol. 15, no. 24, Dec. 2009, pp. 7451–52. Scopus, doi:10.1158/1078-0432.CCR-09-2523.
Kopetz S, Abbruzzese JL. Barriers to integrating gene profiling for stage II colon cancer. Clinical Cancer Research. 2009 Dec 15;15(24):7451–7452.
Published In
Clinical Cancer Research
DOI
ISSN
1078-0432
Publication Date
December 15, 2009
Volume
15
Issue
24
Start / End Page
7451 / 7452
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis